The latest omni-channel platform extension gives pharma access to up to 84% of prioritized HCPs on social media with content that is specific to their specialty

 OptimizeRx Corp., a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced a major extension of its omni-channel platform reach through an exclusive partnership with Equals 5. The new extension is the only healthcare provider (HCP)-level solution providing targeted physician engagement on social media platforms. The partnership marks the first time real-world data from healthcare and social data can be used in combination to deliver valuable treatment information to physicians on social media platforms.

“We chose to collaborate with OptimizeRx because we were looking for a partner with capabilities and data that, together, could enhance both our technologies, creating true omni-channel coverage in reaching HCPs,” commented Ron Scalici, co-founder of Equals 5. “OptimizeRx’s application of AI to real-world data assets that can determine the right time to engage HCPs – at the moment their patients most need it – is unique in the market, and perfectly complements the technology we’ve built which enables us to reach those same HCPs on social media. We couldn’t be more excited about the possibilities to make meaningful connections between life sciences and physicians this way.”

The only HCP-level engagement solution offering true-omni channel reach
Life sciences organizations can now confidently deliver the same message on webpages, social media, and clinical workflow from within a single healthcare communications platform. The Company’s “Therapy Initiation and Persistence Platform,” is the only HCP engagement solution that offers true omni-channel reach at the physician-level including:

1. in the electronic health record (EHR), throughout the full clinical workflow,
2. online and behind the firewalls at the majority of health systems in the United States, and
3. now, on Facebook and Instagram

allowing for true surround sound of brand awareness for life sciences.

Marketing Technology News: 8DAO: Asia’s first Social DAO, using social capital to build a Web3 ecosystem

Steve Silvestro, chief commercial officer at OptimizeRx, stated, “We’re extremely impressed by the Equals 5 technology. On initial testing, we’re seeing average match results for up to 84% of the HCPs that our clients have prioritized to reach on social media. Our partnership means that life sciences companies now have a true option for the reinforcement of their messaging that is specific to an HCP’s specialty across all digital channels – from one entry point: our Therapy Initiation and Persistence Platform. This powerful platform enhancement creates a new avenue for specialty brand amplification outside of the EHR.”

Organizations taking a highly structured approach to their social media strategies see 20-40% higher engagement with their audiences overall, according to a recent McKinsey analysis⁽¹⁾. What this means for life sciences companies is the ability to truly engage with their customers on social media in a more meaningful and productive way with the ability to execute on more integrated engagement strategies.

Will Febbo, OptimizeRx CEO, noted, “The launch of this extension is part of the transformational digital shift in healthcare that we are leading. The offering is a true industry game changer and opens the opportunity for life sciences companies to broadly reach HCPs through social media channels, including Facebook and Instagram. Our Therapy Initiation and Persistence Platform is the only HCP engagement solution that combines true interoperability between longitudinal patient data, the EHR – and now social media – to deliver healthcare resources to physicians and patients based on an HCP’s actual patient population.”

Marketing Technology News: MarTech Interview with Gaurav Chand, Chief Marketing Officer at Cognizant